Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 6:57 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2041–2064 of 2,494 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Spinal Clear all

Conditions: Brain Tumors
Interventions: Induction therapy (Regimen 1, Course 1, Cycle A1, Regimen 1, Course 1, Cycle A2 (Days 22 - 42), Cycle B, Regimen 1, Course 2, Intrathecal Mafosfamide, Regimen 1 Course 2, IT mafosfamide, Regimen 2, Course 1, Regimen 2, Course, 1, Cycle C1, Regimen 2, Course 2, radiation therapy; Drug · Radiation
Lead sponsor: Baylor College of Medicine; Other
Eligibility: Up to 36 Months
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2006
U.S. locations: 3
States / cities: Durham, North Carolina • Memphis, Tennessee • Houston, Texas

Conditions: Spinal Cord Injuries
Interventions: Group 1 Training Program, Group 2 Training Program; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 75 Years
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 4
States / cities: Miami, Florida • Chicago, Illinois • West Orange, New Jersey + 1 more

Conditions: Scoliosis
Interventions: Not listed
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 8 Years to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Spinal Muscular Atrophy
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Not listed
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anhydramnios, Potter Syndrome, Lung Hypoplasia, Multicystic Dysplastic Kidney, Multicystic Renal Dysplasia, Bilateral, Lower Urinary Tract Obstructive Syndrome, Fetal Renal Anomaly
Interventions: Serial amnioinfusions with isotonic fluid, Spinal needle, Isotonic fluid; Procedure · Device · Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2026
U.S. locations: 9
States / cities: Los Angeles, California • San Francisco, California • Stanford, California + 6 more

Conditions: Adolescent Idiopathic Scoliosis
Interventions: Not listed
Lead sponsor: Setting Scoliosis Straight Foundation; Other
Eligibility: 10 Years to 21 Years
Enrollment: 10,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2025
U.S. locations: 12
States / cities: San Diego, California • Wilmington, Delaware • Miami, Florida + 7 more

Conditions: Spinal Muscular Atrophy
Interventions: Onasemnogene Abeparvovec-xioi; Biological
Lead sponsor: Novartis Gene Therapies; Industry
Eligibility: 6 Months to 60 Months
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 11
States / cities: Los Angeles, California • Stanford, California • Orlando, Florida + 8 more

Conditions: Acquired Bleeding Disorder, Spinal Fusion
Interventions: eptacog alfa (activated); Drug
Lead sponsor: Novo Nordisk A/S; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 14
States / cities: Sacramento, California • San Francisco, California • Washington D.C., District of Columbia + 11 more

Conditions: Surgical Anesthesia, Cesarean Section
Interventions: 2% Lidocaine, 3% Chloroprocaine; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Hemangioma
Interventions: MRI, MRI of head and neck, Dermatological Examination, Cardiac examination, Abdominal ultrasound; Device · Other
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: Up to 18 Years
Enrollment: 433 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Elbow Injuries and Disorders, Neuritis, Ulnar, Neuritis, Brachial, Neuritis; Nerve Root, Neuritis Median Nerve
Interventions: Rehabiltiation using exercise and manual therapy; Other
Lead sponsor: Timothy Uhl; Other
Eligibility: 15 Years to 50 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Pelvic Organ Prolapse, Surgery, Postoperative Pain
Interventions: Dexamethasone, Bupivacaine, Bilateral Pudendal Nerve Block, Bilateral Levator Ani Muscle Injection, Saline; Drug · Procedure
Lead sponsor: Lauren Giugale, MD; Other
Eligibility: 18 Years and older · Female only
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Spinal Cord Injury
Interventions: SCI Reinvention Protocol Participants, Waitlist Group; Behavioral · Other
Lead sponsor: Craig Hospital; Other
Eligibility: 18 Years to 100 Years
Enrollment: 81 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Englewood, Colorado

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Spinal Cord Associative Plasticity (SCAP), Upper extremity task-oriented exercise; Procedure
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 80 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Degenerative Disc Disease
Interventions: Virtuos; Device
Lead sponsor: Orthofix Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 3
States / cities: New Britain, Connecticut • Royal Oak, Michigan • Dallas, Texas

Conditions: Spinal Cord Injury
Interventions: Riluzole, Placebo; Drug
Lead sponsor: AOSpine North America Research Network; Network
Eligibility: 18 Years to 75 Years
Enrollment: 193 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 20
States / cities: Phoenix, Arizona • San Jose, California • Miami, Florida + 16 more

Conditions: Muscle Spasticity
Interventions: Baclofen bolus injection; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Cerebrovascular Disorder, Healthy, Movement Disorder, Nervous System Disease, Spinal Cord Injury
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 610 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1992 – 2002
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Spinal Cord Injuries
Interventions: Transcutaneous Spinal Cord Stimulation, Arm-crank bike exercise, Sham Stimulation; Device · Behavioral · Other
Lead sponsor: University of Washington; Other
Eligibility: 21 Years to 65 Years
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Pain, Postoperative, Scoliosis Idiopathic
Interventions: Gabapentin, Placebo; Drug · Other
Lead sponsor: Emory University; Other
Eligibility: 10 Years to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Stem cell (HPC) implantation, Stereotactic surgical device; Biological · Device
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Spinal Muscular Atrophy
Interventions: Risdiplam; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: Not listed
Enrollment: 403 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 37
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Loma Linda, California + 31 more

Conditions: Degenerative Disc Disease, Degenerative Spondylolisthesis
Interventions: SpineLink® , SpineLink® II; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: Not listed
Enrollment: 202 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2009
U.S. locations: 2
States / cities: San Diego, California • Jacksonville, Florida

Conditions: Osteoarthritis, Hip
Interventions: isobaric bupivacaine, hyperbaric bupivacaine, isobaric mepivacaine; Drug
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years to 84 Years
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 2
States / cities: Bensalem, Pennsylvania • Philadelphia, Pennsylvania

Search by objective public record fields.

Study of Systemic and Spinal Chemotherapy Followed by Radiation for Infants With Brain Tumors

Training Programs to Improve Outcomes for Individuals With Spinal Cord Injury

Pharmacokinetics of Aminocaproic Acid in Scoliosis Surgery

Prospective Evaluation of Infants With Spinal Muscular Atrophy:

Renal Anhydramnios Fetal Therapy

Adolescent Idiopathic Scoliosis Outcomes Database Registry

Study of Intrathecal Administration of Onasemnogene Abeparvovec-xioi for Spinal Muscular Atrophy

Use of Activated Recombinant FVII in Spinal Surgery

Comparison of Chloroprocaine vs Lidocaine for Epidural Anesthesia in Cesarean Delivery

Hemangioma Associated With High Rates of Morbidity

Physical Therapy on Non-structural Medial Elbow Pain

Preoperative Levator Ani Muscle Injection and Pudendal Nerve Block for Pain Control After Vaginal Reconstructive Surgery

Re-Inventing Yourself After Spinal Cord Injury

Spinal Cord Associative Plasticity for ALS

Comparative Analysis of Virtuos and Autograft in Lumbar Fusion

Riluzole in Spinal Cord Injury Study

Intrathecal (IT) Baclofen Drug Distribution

Magnetic Resonance Imaging Studies of Motor and Thought Processes

Transcutaneous Spinal Cord Stimulation Combined With Arm Bike for Cardiovascular Recovery in SCI

Gabapentin and Chronic Post Surgical Pain

CNS10-NPC-GDNF for the Treatment of ALS

Long-term Follow-up Study of Risdiplam in Participants With Spinal Muscular Atrophy (SMA)

Evaluation Of Spinelink® Fixation In The Treatment Of Degenerative Spondylolisthesis And Spinal Instability

3 Local Anesthetics for Spinal Anesthesia in Primary Total Hip Arthroplasty